Results 41 to 50 of about 596 (171)
Peritoneovenous shunts have become an accepted mode of therapy for ascites refractory to medical treatment. However, their use is known to be associated with significant morbidity and mortality.
Taylor, Anne L. +4 more
core +1 more source
Abstract The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita +116 more
wiley +1 more source
Intestinal Obstruction in a Patient with Sclerosing Encapsulating Peritonitis
Sclerosing encapsulating peritonitis (SEP) is a rare disorder that is characterized by encapsulation of bowel loops by thick fibrinogenous case. Most patients present with vague abdominal symptoms. It is challenging to diagnose the condition preoperatively.
Oday Obaid +3 more
wiley +1 more source
The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX© Catheter
Background. Treatment options are limited for patients with refractory cirrhotic ascites (RCA). As such, we assessed the safety and effectiveness of the PleurX catheter for RCA. Methods. A retrospective analysis was performed on all patients with RCA who have undergone insertion of the PleurX catheter between 2007 and 2014 at our clinic.
Jason Reinglas +5 more
wiley +1 more source
Peritoneovenous shunt in the management of ascites and the hepatorenal syndrome
In summary, the peritoneovenous shunt as a means of relieving ascites offers a great deal to appropriately selected patients. It has some serious complications however, and should not be used indiscriminately.
Epstein, Murray
core +1 more source
Peritoneovenous shunt for palliation of carcinomatous ascites [PDF]
La ascitis carcinomatosa (AC), suele ser manifestación de una neoplasia con metástasis. El objetivo de este estudio ha sido evaluar la utilidad del shunt peritoneovenoso (SPV) , en pacientes con AC refractaria al tratamiento convencional.
Guardiola, Jordi +5 more
core
ABSTRACT Intraperitoneal administration of depot corticosteroids following an initial paracentesis reduces ascitic fluid formation and extends the interval between subsequent paracentesis sessions. This approach may effectively manage recurrent malignant ascites and enhance patients' quality of life.
Nashid Islam +3 more
wiley +1 more source
Aim. To explore the potential factors that influence the presentation and recovery of postoperative chylous ascites (CA) in gynecological malignancies. Methods. We reported two cases of postoperative CA following gynecological surgery and reviewed the clinical features of 140 patients from 16 relevant papers.
Xin Tan +4 more
wiley +1 more source
We report a case of superior vena cava (SVC) thrombosis in a patient with liver cirrhosis and peritoneovenous surgical Denver shunt, successfully treated by angioplasty.
Bonomo, Lorenzo +20 more
core +1 more source
Peritoneovenous Shunts for Palliation of Malignant Ascites
Malignant ascites may produce a cluster of symptoms that include abdominal distention, early satiety, respiratory embarrassment, impaired mobility, and lethargy, and relief of these symptoms is often difficult to achieve. We report on the placement of peritoneovenous shunts (PVSs) in a group of patients with malignant ascites, with particular reference
Mamada, Yasuhiro +9 more
openaire +3 more sources

